Let’s talk about how we can work together to advance bioengineering.
A new exoskeleton spine brace promises to offer children and teens with scoliosis more mobility and comfort than traditional braces.
AABME is a new site offering a range of professional and networking resources to bridge the gap between basic research and applied research. Join the alliance to connect with other practitioners and gain access to premium content – at no cost.
Albert Manero, President of Limbitless Solutions, describes the groundbreaking work he and his team are doing in the fields of prosthetics and bionics, work that includes a brush with fame in the form of a certain Marvel superhero.
To a surgeon, a useful model organ needs to be more than a rigid plastic curio. It needs the feel of the real thing if it’s to be any good for practice. Now researchers have created a 3D printed organ with the elasticity of flesh and blood.
Testing drugs against patients’ cancer cells—without subjecting patients to chemotherapy—could lead to better, faster treatment.
A new breakthrough in anti-aging research could lead to gene and stem cell therapies that turn back the hands of time.
Based on the mechanism that manipulates professional flight simulators, a new robot could help surgeons realign the largest bone in the body.
A research lab has found an innovative way to close the gap between low-tech passive ankle prostheses and high-tech robotics.
Researchers at the University of Pittsburgh’s Center for Cellular and Molecular Engineering have developed a small bioreactor that grows constructs of bone and cartilage in a single chamber.
Regenerative medicine searches for ways to move into larger tests and commercial products.
A combined bioreactor and cell culture analyzer automatically monitors and adjusts growing conditions on 48 different cell cultures.
This “skin on a chip” bioreactor can help researchers study and treat keloid disease and other forms of extreme scarring.
A new system may help solve the problem of shipping cells between laboratories and hospitals and clinics by developing an alternative to cryopreservation.
Engineering and manufacturing expertise could ease the shortage of viral vectors used for drug delivery in the booming gene therapy market.